ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Vectura to advance asthma inhaler after phase 2 studies show ease of use by young children
August 22, 2018Vectura unveiled positive results from two phase 2 studies evaluating the ability of young children and toddlers with asthma to use its nebulized inhaler, suggesting that its VR647 budesonide system could reduce delivery times and lower steroid doses comp
Pharma Sources Insight January 2025
